» Articles » PMID: 39503145

Efficacy of QuickSleeper Intraosseous Injection of 4% Articaine in Mandibular First Molars With Symptomatic Irreversible Pulpitis: A Randomized Controlled Trial

Overview
Journal Anesth Prog
Date 2024 Nov 6
PMID 39503145
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the anesthetic efficacy of 4% articaine with 1:100,000 epinephrine via primary intraosseous (IO) injection with the QuickSleeper device vs inferior alveolar nerve block (IANB) for mandibular first molars diagnosed with symptomatic irreversible pulpitis (SIP).

Methods: Sixty-four patients with a first mandibular molar with SIP were randomly divided into 2 groups: IO (n = 32) and IANB (n = 32). Each received either an IO injection with the 5th generation QuickSleeper device or a conventional IANB with 1.7 mL 4% articaine with 1:100,000 epinephrine. Success was defined as no/mild pain upon the access cavity preparation and initial filing. Injection pain, anesthetic onset, heart rate (HR) change, HR recovery time, and duration of anesthesia were also recorded and analyzed.

Results: The success rates were 40.6% for IANB and 81.2% for IO (P < .001). IO exhibited a significantly lower injection pain (P = .027), a shorter onset of action (P < .001), a greater heart rate increase (P < .001), a faster heart rate recovery time (P < .001), and a shorter duration of action (P < .001) vs IANB.

Conclusion: Primary IO anesthesia using the fifth generation of the QuickSleeper device was more successful than IANB when using 4% articaine with 1:100,000 epinephrine to anesthetize mandibular first molars with SIP. The QuickSleeper device appeared to be a viable alternative to IANB for mandibular anesthesia.

References
1.
Stirrup P, Crean S . Does articaine, rather than lidocaine, increase the risk of nerve damage when administered for inferior alveolar nerve blocks in patients undergoing local anaesthesia for dental treatment? A mini systematic review of the literature. Br Dent J. 2019; 226(3):213-223. DOI: 10.1038/sj.bdj.2019.98. View

2.
Oertel R, Rahn R, Kirch W . Clinical pharmacokinetics of articaine. Clin Pharmacokinet. 1998; 33(6):417-25. DOI: 10.2165/00003088-199733060-00002. View

3.
Attar S, Bowles W, Baisden M, Hodges J, McClanahan S . Evaluation of pretreatment analgesia and endodontic treatment for postoperative endodontic pain. J Endod. 2008; 34(6):652-5. DOI: 10.1016/j.joen.2008.02.017. View

4.
Razavian H, Kazemi S, Khazaei S, Jahromi M . X-tip intraosseous injection system as a primary anesthesia for irreversible pulpitis of posterior mandibular teeth: A randomized clinical trail. Dent Res J (Isfahan). 2013; 10(2):210-3. PMC: 3731962. DOI: 10.4103/1735-3327.113346. View

5.
Facco E, Zanette G, Favero L, Bacci C, Sivolella S, Cavallin F . Toward the validation of visual analogue scale for anxiety. Anesth Prog. 2011; 58(1):8-13. PMC: 3265269. DOI: 10.2344/0003-3006-58.1.8. View